LGR6 and ovarian cancer: The relevance of the GPCR/β-arrestin pathway in ovarian cancer cells is demonstrated by the finding that endothelin-1 receptor/β-arrestin complex activates beta-catenin signaling pathways with impact on carcinogenesis and metastatic progression (11).